What is he best known for?
The fields of study he is best known for:
- Gene
- Cancer
- Immune system
Steven T. Pals focuses on Cancer research, Immunology, Cell biology, Cell adhesion and Lymphocyte homing receptor.
His Cancer research study integrates concerns from other disciplines, such as Wnt signaling pathway, Carcinogenesis, Receptor tyrosine kinase, Colorectal cancer and Bruton's tyrosine kinase.
His biological study spans a wide range of topics, including T cell, Naive B cell and Programmed cell death.
His Programmed cell death study incorporates themes from Annexin, Annexin A5 affinity assay and Annexin A2.
In his study, which falls under the umbrella issue of Cell adhesion, Cell–cell interaction is strongly linked to Cell adhesion molecule.
His studies deal with areas such as T lymphocyte, Neural cell adhesion molecule, Intercellular adhesion molecule and Lymphoma as well as Lymphocyte homing receptor.
His most cited work include:
- Annexin V for flow cytometric detection of phosphatidylserine expression on B cells undergoing apoptosis. (2337 citations)
- Expression of CD44 Variant Proteins in Human Colorectal Cancer Is Related to Tumor Progression (503 citations)
- Expression of CD44 in Apc and Tcf Mutant Mice Implies Regulation by the WNT Pathway (442 citations)
What are the main themes of his work throughout his whole career to date?
Immunology, Cancer research, Pathology, Molecular biology and Cell biology are his primary areas of study.
His Immunology research includes elements of Receptor and Cell adhesion.
The study incorporates disciplines such as CD44, Receptor tyrosine kinase, Signal transduction, Lymphoma and Colorectal cancer in addition to Cancer research.
In his work, Wnt signaling pathway is strongly intertwined with Carcinogenesis, which is a subfield of Colorectal cancer.
His Molecular biology research incorporates elements of CD40, Antigen-presenting cell and Antibody, Germinal center, B cell.
His Cell biology research integrates issues from T cell, Biochemistry, Neural cell adhesion molecule and Programmed cell death.
He most often published in these fields:
- Immunology (29.69%)
- Cancer research (29.69%)
- Pathology (18.75%)
What were the highlights of his more recent work (between 2012-2021)?
- Cancer research (29.69%)
- Immunology (29.69%)
- Internal medicine (12.50%)
In recent papers he was focusing on the following fields of study:
His primary scientific interests are in Cancer research, Immunology, Internal medicine, Lymphoma and MEDLINE.
His Cancer research study also includes
- Chronic lymphocytic leukemia which is related to area like CD40,
- Mantle cell lymphoma, which have a strong connection to CD5, Tyrosine kinase and Naive B cell.
He regularly ties together related areas like Stem cell in his Immunology studies.
The various areas that Steven T. Pals examines in his Internal medicine study include Gastroenterology, CD44 and Oncology.
Pathology covers he research in Lymphoma.
His research investigates the connection between Inflammation and topics such as T cell that intersect with issues in Apoptosis.
Between 2012 and 2021, his most popular works were:
- A case of meningoencephalitis by the relapsing fever spirochaete Borrelia miyamotoi in Europe (159 citations)
- Egress of CD19+CD5+ cells into peripheral blood following treatment with the Bruton tyrosine kinase inhibitor ibrutinib in mantle cell lymphoma patients (151 citations)
- IL-21 and CD40L signals from autologous T cells can induce antigen-independent proliferation of CLL cells (76 citations)
In his most recent research, the most cited papers focused on:
- Gene
- Cancer
- Immune system
His primary areas of study are Immunology, Ibrutinib, Cancer research, Bruton's tyrosine kinase and Biopsy.
His research in Immunology intersects with topics in Phenotype and Cell.
He combines subjects such as Immunohistochemistry, Lymphoma, Rituximab, Pathology and Chemotherapy with his study of Ibrutinib.
His research integrates issues of Chronic lymphocytic leukemia and FOXP1 in his study of Cancer research.
His Bruton's tyrosine kinase study combines topics in areas such as Idelalisib and Cell adhesion.
His Haematopoiesis research is multidisciplinary, relying on both Heparan sulfate and Molecular biology.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
